Maria Cecilia Soriano is Group President, Infusion Therapies & Technologies & Pharmaceuticals at Baxter International. She was appointed to her current role in 2025 after serving as President, Infusion Therapies & Technologies since 2023.
Prior to joining Baxter, Ms. Soriano served in roles of increasing responsibility at Becton, Dickinson and Company, including as Global Vice President and General Manager, Microbiology from 2020 to 2023; U.S. Vice President and General Manager, Diabetes Care; Senior Vice President, Global Marketing and Strategy; and Vice President, Strategic Marketing.
Previously, she worked at Johnson & Johnson, The Coca-Cola Company and Citibank, N.A. Ms. Soriano currently serves as a member of the board of directors of ScionHealth.